These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12496998)

  • 1. Clearance rates of total prostate specific antigen (PSA) after radical prostatectomy in African-Americans and Caucasians.
    Lotan Y; Roehrborn CG
    Prostate Cancer Prostatic Dis; 2002; 5(2):111-4. PubMed ID: 12496998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of race on prostate-specific antigen outcome after radical prostatectomy for clinically localized adenocarcinoma of the prostate.
    Cross CK; Shultz D; Malkowicz SB; Huang WC; Whittington R; Tomaszewski JE; Renshaw AA; Richie JP; D'Amico AV
    J Clin Oncol; 2002 Jun; 20(12):2863-8. PubMed ID: 12065563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. African-American men with prostate cancer have larger tumor volume than Caucasian men despite no difference in serum prostate specific antigen.
    Fuletra JG; Kamenko A; Ramsey F; Eun DD; Reese AC
    Can J Urol; 2018 Feb; 25(1):9193-9198. PubMed ID: 29524974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.
    Moul JW; Sesterhenn IA; Connelly RR; Douglas T; Srivastava S; Mostofi FK; McLeod DG
    JAMA; 1995 Oct; 274(16):1277-81. PubMed ID: 7563532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial differences in serum prostate-specific antigen (PSA) doubling time, histopathological variables and long-term PSA recurrence between African-American and white American men undergoing radical prostatectomy for clinically localized prostate cancer.
    Tewari A; Horninger W; Badani KK; Hasan M; Coon S; Crawford ED; Gamito EJ; Wei J; Taub D; Montie J; Porter C; Divine GW; Bartsch G; Menon M
    BJU Int; 2005 Jul; 96(1):29-33. PubMed ID: 15963115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of clinical and pathological features in African-American and Caucasian patients with localized prostate cancer.
    Kang JS; Maygarden SJ; Mohler JL; Pruthi RS
    BJU Int; 2004 Jun; 93(9):1207-10. PubMed ID: 15180606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-specific antigen (PSA) and PSA density: racial differences in men without prostate cancer.
    Henderson RJ; Eastham JA; Culkin DJ; Kattan MW; Whatley T; Mata J; Venable D; Sartor O
    J Natl Cancer Inst; 1997 Jan; 89(2):134-8. PubMed ID: 8998182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate-specific antigen levels are higher in African-American than in white patients in a multicenter registration study: results of RTOG 94-12.
    Vijayakumar S; Winter K; Sause W; Gallagher MJ; Michalski J; Roach M; Porter A; Bondy M
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):17-25. PubMed ID: 9422553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical stage T1c prostate cancer: pathologic outcomes following radical prostatectomy in black and white men.
    Eastham JA; Carver B; Katz J; Kattan MW
    Prostate; 2002 Mar; 50(4):236-40. PubMed ID: 11870801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. African-American Men with Gleason Score 3+3=6 Prostate Cancer Produce Less Prostate Specific Antigen than Caucasian Men: A Potential Impact on Active Surveillance.
    Kryvenko ON; Balise R; Soodana Prakash N; Epstein JI
    J Urol; 2016 Feb; 195(2):301-6. PubMed ID: 26341575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate specific antigen kinetics at tumor recurrence after radical prostatectomy do not suggest a worse disease prognosis in black men.
    Bissonette EA; Fulmer BR; Petroni GR; Moul JW; Theodorescu D
    J Urol; 2001 Oct; 166(4):1328-31; discussion 1331-2. PubMed ID: 11547067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cPSA and fPSA elimination in African-American men.
    Martin BJ; Cheli C; Davis R; Ward M; Kokatnur M; Mercante D; Lifsey D; Rayford W
    Prostate Cancer Prostatic Dis; 2003; 6(2):163-8. PubMed ID: 12806377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer stage shift has eliminated the gap in disease-free survival in black and white American men after radical prostatectomy.
    Bianco FJ; Wood DP; Grignon DJ; Sakr WA; Pontes JE; Powell IJ
    J Urol; 2002 Aug; 168(2):479-82. PubMed ID: 12131292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in radical prostatectomy and radiation therapy rates for African Americans and whites.
    Shaw M; Elterman L; Rubenstein M; McKiel CF; Guinan P
    J Natl Med Assoc; 2000 Jun; 92(6):281-4. PubMed ID: 10918763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease recurrence in black and white men undergoing radical prostatectomy for clinical stage T1-T2 prostate cancer.
    Eastham JA; Kattan MW
    J Urol; 2000 Jan; 163(1):143-5. PubMed ID: 10604332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. African-American men with nonpalpable prostate cancer exhibit greater tumor volume than matched white men.
    Sanchez-Ortiz RF; Troncoso P; Babaian RJ; Lloreta J; Johnston DA; Pettaway CA
    Cancer; 2006 Jul; 107(1):75-82. PubMed ID: 16736511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial differences in prostate cancer growth: apoptosis and cell proliferation in Caucasian and African-American patients.
    Guo Y; Sigman DB; Borkowski A; Kyprianou N
    Prostate; 2000 Feb; 42(2):130-6. PubMed ID: 10617870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Race is not an independent predictor of biochemical recurrence after radical prostatectomy in an equal access medical center.
    Freedland SJ; Jalkut M; Dorey F; Sutter ME; Aronson WJ
    Urology; 2000 Jul; 56(1):87-91. PubMed ID: 10869631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Korean prostate cancer patients have worse disease characteristics than their American counterparts.
    Kang DI; Chung JI; Ha HK; Min K; Yoon J; Kim W; Seo WI; Kang Pm; Jung SJ; Kim IY
    Asian Pac J Cancer Prev; 2013; 14(11):6913-7. PubMed ID: 24377625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between presentation PSA and race in two sequential time periods in prostate cancer patients seen at a university hospital and its community affiliates.
    Pan CC; Lee JS; Chan JL; Sandler HM; Underwood W; McLaughlin PW
    Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1292-6. PubMed ID: 14630264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.